So that may be something that we try
After that, you risk gradual degradation, which could impact your research results
Whats more, a recent retrospective, multicenter cohort study denied higher occurrence of nonarteritic anterior ischemic optic neuropathy (NAION) in GLP-1RAs users and suggested that its potential benefits for blood glucose control and cardiovascular health likely outweigh its risks (Chou et al., 2025), despite that a few research have reported association between semaglutide prescription and a higher risk of NAION(61)
The consistent pharmacokinetic profile across injection sites simplifies administration for patients, allowing them to choose sites based on comfort, convenience, and proper rotation practices
Anne Geggis is statewide reporter for the USA TODAY NETWORK FLORIDA, reporting on health and senior issues